{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:30:23Z","timestamp":1786987823792,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["23-0112"],"award-info":[{"award-number":["23-0112"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013710","name":"European Federation of Immunological Societies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ebiom.2026.106314","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:14:02Z","timestamp":1780013642000},"page":"106314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis"],"prefix":"10.1016","volume":"128","author":[{"given":"Elena","family":"Ellmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4089-6740","authenticated-orcid":false,"given":"Alyssa","family":"Schnabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9825-1170","authenticated-orcid":false,"given":"Julia","family":"Meissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Stracke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Rittchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"St\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Passegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8538-0527","authenticated-orcid":false,"given":"Lena","family":"Schwarzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Tafrali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Demjaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martinez-Serrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8496-1666","authenticated-orcid":false,"given":"Lisa-Carina","family":"Zeiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Topler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Klemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Heschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Damulina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marah C.","family":"Runtsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Fessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-3328","authenticated-orcid":false,"given":"Michael","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4434-2224","authenticated-orcid":false,"given":"Stefano","family":"Angiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10422","key":"10.1016\/j.ebiom.2026.106314_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106314_bib2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106314_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s43440-024-00642-0","article-title":"Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects","volume":"76","author":"Olejnik","year":"2024","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.ebiom.2026.106314_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578315","article-title":"Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis","volume":"390","author":"Sriwastava","year":"2024","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106314_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1626","article-title":"Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: tipping the balance of T- and B-cell interactions","volume":"14","author":"Barberis","year":"2024","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jnc.15169","article-title":"Metabolic determinants of leukocyte pathogenicity in neurological diseases","volume":"158","author":"Runtsch","year":"2021","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","article-title":"Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis","volume":"21","author":"Wang","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.ebiom.2026.106314_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2020.00159","article-title":"Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis","volume":"10","author":"Zahra","year":"2020","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106314_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cmet.2015.01.017","article-title":"Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the warburg effect in LPS-activated macrophages","volume":"21","author":"Palsson-McDermott","year":"2015","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106314_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106314_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107690","article-title":"Pyruvate kinase M2 promotes the activation of dendritic cells by enhancing IL-12p35 expression","volume":"31","author":"Jin","year":"2020","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106314_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190613","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation","volume":"217","author":"Damasceno","year":"2020","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106314_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127395","article-title":"Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation","volume":"4","author":"Kono","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12974-024-03270-w","article-title":"Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation","volume":"21","author":"Angiari","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106314_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106314_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"655","key":"10.1016\/j.ebiom.2026.106314_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay9217","article-title":"Modulation of PKM activity affects the differentiation of TH17 cells","volume":"13","author":"Seki","year":"2020","journal-title":"Sci Signal"},{"key":"10.1016\/j.ebiom.2026.106314_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59166","article-title":"Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses","volume":"9","author":"Walls","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib20","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1038\/s41467-023-40021-6","article-title":"The metabolic function of pyruvate kinase M2 regulates reactive oxygen species production and microbial killing by neutrophils","volume":"14","author":"Toller-Kawahisa","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4049\/jimmunol.1600613","article-title":"Homocysteine activates B cells via regulating PKM2-Dependent metabolic reprogramming","volume":"198","author":"Deng","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106314_bib23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41423-024-01124-2","article-title":"CD8+ T cell metabolic flexibility elicited by CD28-ARS2 axis-driven alternative splicing of PKM supports antitumor immunity","volume":"21","author":"Holling","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106314_bib24","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41590-024-01963-1","article-title":"Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy","volume":"25","author":"Markowitz","year":"2024","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106314_bib25","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2025.03.003","article-title":"Pyruvate kinase M2 activation reprograms mitochondria in CD8 T cells, enhancing effector functions and efficacy of anti-PD1 therapy","volume":"37","author":"Mortazavi Farsani","year":"2025","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13293-020-00301-y","article-title":"Biol sex differ. The impact of sex and gender on immunotherapy outcomes","volume":"11","author":"Klein","year":"2020","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.ebiom.2026.106314_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103409","article-title":"Senescent T cells: a potential biomarker and target for cancer therapy","volume":"68","author":"Zhang","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106314_bib28","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0242","article-title":"Role of CD20+ T cells in cancer, autoimmunity and obesity","volume":"260","author":"Pinho","year":"2024","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ebiom.2026.106314_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.706434","article-title":"The role of T cell senescence in neurological diseases and its regulation by cellular metabolism","volume":"12","author":"Fessler","year":"2021","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106314_bib30","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.3390\/ijms25168987","article-title":"Current knowledge about CD3+CD20+ T cells in patients with multiple sclerosis","volume":"25","author":"Arneth","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106314_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111897","article-title":"Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation","volume":"41","author":"Veras","year":"2022","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106314_bib32","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028944","article-title":"Lifestyle and environmental factors in multiple sclerosis","volume":"9","author":"Alfredsson","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106314_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00415-026-13704-5","article-title":"Disability progression in multiple sclerosis: a latent class analysis of predictors","volume":"273","author":"Guo","year":"2026","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106314_bib34","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.bmcl.2010.04.015","article-title":"Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase","volume":"20","author":"Jiang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"issue":"25","key":"10.1016\/j.ebiom.2026.106314_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat1604","article-title":"Type 2 immunity: expanding our view","volume":"3","author":"Lloyd","year":"2018","journal-title":"Sci Immunol"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106314_bib36","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.3390\/ijms25169108","article-title":"An IL-5 single-nucleotide polymorphism influences neuroinflammation and prospective disease activity in multiple sclerosis","volume":"25","author":"Dolcetti","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106314_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.2003.02238.x","article-title":"Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis","volume":"133","author":"Wiesemann","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib38","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200322","article-title":"Proteomics reveals age as major modifier of inflammatory CSF signatures in multiple sclerosis","volume":"12","author":"Held","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106314_bib39","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1177\/1352458519852092","article-title":"T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients","volume":"26","author":"Ghezzi","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.ebiom.2026.106314_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1101379","article-title":"The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis","volume":"17","author":"Angelini","year":"2023","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","article-title":"TH17 cell heterogeneity and its role in tissue inflammation","volume":"24","author":"Schnell","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2026.106314_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/srep24491","article-title":"Integrative phosphoproteomics links IL-23R signaling with metabolic adaptation in lymphocytes","volume":"6","author":"Lochmatter","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-018-1105-9","article-title":"Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients","volume":"15","author":"Canto","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106314_bib44","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/eji.201948470","article-title":"Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer","volume":"50","author":"Kurniawan","year":"2020","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106314_bib46","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s40120-023-00549-7","article-title":"No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]","volume":"12","author":"Newsome","year":"2023","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106314_bib47","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209444","article-title":"Using the progression independent of relapse activity framework to unveil the pathobiological foundations of multiple sclerosis","volume":"103","author":"Ciccarelli","year":"2024","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106314_bib48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/08923973.2022.2086139","article-title":"Triptolide inhibits Th17 differentiation via controlling PKM2-mediated glycolysis in rheumatoid arthritis","volume":"44","author":"Shen","year":"2022","journal-title":"Immunopharmacol Immunotoxicol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:12:27Z","timestamp":1783102347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S2352396426001969"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106314","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106314"}}